Asiri Surgical Hospital Plc

  • Market Cap: Small Cap
  • Industry: Hospital
  • ISIN: LK0344N00008
LKR
13.30
1.7 (14.66%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Asiri Surgical Hospital Plc stock-summary
stock-summary
Asiri Surgical Hospital Plc
Hospital
Asiri Surgical Hospital PLC is a provider of healthcare and hospital services. The Company is principally engaged in operating a two-tier hospital. The Company's hospital surgical services include general surgery; plastic surgery; cardiology; ear, nose, and throat (ENT) surgery; oncology, and orthopedics. Its hospital provides facilities, such as emergency treatment unit (ETU), positron emission tomography-computed tomography (PET-CT) scanner, physiotherapy and rehabilitation unit, dental unit, blood transfusion service, one-five Tesla multifunctional magnetic resonance imaging (MRI) scanning system, nine-bed intensive care unit (ICU), 64 slice/second spiral computed tomography (CT) scanner, four-dimensional (4D) real time ultrasound scanning system, digital x-ray system, mammography system, electroencephalogram/electromyography (EEG/EMG), chemotherapy ward and stem-cell unit. Asiri Hospital Holdings PLC is the Company's parent company.
Company Coordinates stock-summary
Company Details
No 21, Kirimandala Mawatha, Colombo 5 , COLOMBO None : 5
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Ashok Pathirage
Executive Chairman of the Board, Managing Director
Dr. Sivakumar Selliah
Independent Non-Executive Deputy Chairman of the Board
Dr. Karunamuni Karunaratne
Chief Operating Officer, Director - Medical, Executive Director
Mr. Samantha Rajapaksa
Non-Executive Director
C. Weerasinghe
Non-Executive Director
Mr. G. Premaratne
Independent Non-Executive Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
1,900 Million
(Quarterly Results - Jun 2025)
Net Profit:
202 Million
stock-summary
Industry

Hospital

stock-summary
Market cap

LKR Million (Small Cap)

stock-summary
P/E

0

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.36

stock-summary
Return on Equity

11.00%

stock-summary
Price to Book

0.00